TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy November 25, 2011
